As recent studies have indicated that agents capable of improving insulin sensitivity may be of great value in the treatment of T2DM, it is highly important to investigate whether insulin resistance and its clinical correlates can be reversed using therapies aimed at the neutralisation of TNF-α. The gene discussed is INS; the disease is Insulin resistance.